ME
BGMS

McIlrath & Eck’s Bio Green Med Solution Inc BGMS Stock Holding History

McIlrath & Eck’s Portfolio BGMS Stock Details BGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1
Closed -$164 – 988
2024
Q3 		$164 Sell
1
-2
-67% -$645 ﹤0.01% 958
2024
Q2 		$1.35K Hold
3
– – ﹤0.01% 851
2024
Q1 		$1.75K Hold
3
– – ﹤0.01% 827
2023
Q4 		$2.22K Hold
3
– – ﹤0.01% 797
2023
Q3 		$4.43K Hold
3
– – ﹤0.01% 675
2023
Q2 		$5.89K Sell
3
-4
-57% -$8.92K ﹤0.01% 641
2023
Q1 		$15K Hold
7
– – ﹤0.01% 469
2022
Q4 		$17.6K Hold
7
– – ﹤0.01% 434
2022
Q3 		$38K Buy
+7
New +$35.6K 0.01% 289

Other funds holding BGMS

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VWA
VSM Wealth Advisory Hunt Valley, Maryland $376M AUM 21.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
AIC
Archer Investment Corporation Carmel, Indiana $508M AUM 24.82% 1-Year Est. Return

McIlrath & Eck's BGMS Position: Q4 2024 in Review

McIlrath & Eck sold out of Bio Green Med Solution Inc (BGMS) in Q4 2024, closing a stake of 1 share — an estimated $164 sold.

McIlrath & Eck first reported a position in BGMS in Q3 2022 and held it in 9 quarters. The position peaked at $38K in Q3 2022. 13 funds tracked by Wall St. Rank hold BGMS as of Q4 2024.

  • McIlrath & Eck reported no remaining Bio Green Med Solution Inc position as of Q4 2024 after selling out during the quarter.
  • McIlrath & Eck sold 1 Bio Green Med Solution Inc share in Q4 2024, an estimated $164.
  • McIlrath & Eck first reported a position in Bio Green Med Solution Inc in Q3 2022 and held it in 9 quarters.
  • McIlrath & Eck's Bio Green Med Solution Inc position peaked at $38K in Q3 2022.
  • 13 funds tracked by Wall St. Rank held Bio Green Med Solution Inc as of Q4 2024.

Based on McIlrath & Eck's 13F filing for Q4 2024, filed 18 Feb 2025.